• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Lumexa Imaging Achieves Record De Novo Expansion in 2025

    1/8/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care
    Get the next $LMRI alert in real time by email

    Company opens nine new outpatient imaging centers, expanding access to high-quality, cost-effective care

    RALEIGH, N.C., Jan. 8, 2026 /PRNewswire/ -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, set a company record by opening nine de novo centers in 2025. The two newest centers, located in Anderson, South Carolina and Cotswold, North Carolina, opened in December. With these new locations Lumexa Imaging now operates more than 185 centers across 13 states. The prior 2025 openings took place across New York, South Carolina and Texas.

    Lumexa Imaging Logo (PRNewsfoto/Lumexa Imaging)

    "Our consistent success executing on our de novo strategy, including a record year in 2025, is a testament to our team's commitment and the value we deliver to patients and stockholders alike," said Caitlin Zulla, CEO of Lumexa Imaging. "Improving the lives of our patients is what drives us to strategically expand access to high-quality imaging through elevated, compassionate care. In 2026, we aspire to continue advancing healthcare across the country through opening more de novos both independently and with our joint venture partners."

    With an aging population and an increase in both chronic and complex conditions, freestanding outpatient imaging centers like those operated by Lumexa Imaging play a critical role in providing accessible high-quality care. With extended hours and easily accessible retail locations in some of the fastest growing metropolitan statistical areas (MSAs) of the country, Lumexa Imaging's centers make it easy for patients to complete imaging exams, including MRIs, CTs, and PET/CTs, that help diagnose disease and guide appropriate treatment – typically at a lower cost compared to hospital-based alternatives.

    "Lumexa Imaging's de novo growth strategy is focused on high-growth MSAs" said Lumexa Imaging Chief Growth Officer Chris Core. "Through this targeted strategy, Lumexa Imaging has built the second largest footprint of outpatient imaging centers in the nation, and we intend to continue that momentum in 2026 as we deliver continued growth for all of our stakeholders."

    About Lumexa Imaging

    Lumexa Imaging (NASDAQ:LMRI) is a nationwide provider of outpatient medical imaging. With over 5,000 team members and more than 185 outpatient imaging centers across 13 states, our team conducted approximately 4 million outpatient scans in 2024. We are a partner of choice for health systems and radiologists, delivering best-in-class clinical excellence, operations, and state-of-the-art technology across our platform.

    Forward-Looking Statements

    Certain statements contained in this press release are forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact contained in this press release, including statements regarding our future openings of de novo centers, business strategy and plans and objectives of management for future operations, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.

    In some cases, you can identify forward-looking statements by terms such as "may," "would," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar expressions. The forward-looking statements in this press release are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition, results of operations, liquidity and stock price. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. 

    Forward-looking statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein.

    Media Contact

    Melissa Weston

    [email protected]

    IR Contact

    IR@lumexaimaging.com 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lumexa-imaging-achieves-record-de-novo-expansion-in-2025-302655934.html

    SOURCE Lumexa Imaging

    Get the next $LMRI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LMRI

    DatePrice TargetRatingAnalyst
    2/9/2026$23.00Outperform → Strong Buy
    Raymond James
    1/5/2026$23.00Overweight
    Analyst
    1/5/2026$23.00Buy
    Jefferies
    1/5/2026$22.00Overweight
    Wells Fargo
    1/5/2026Outperform
    William Blair
    1/5/2026$23.00Outperform
    Raymond James
    1/5/2026$23.00Outperform
    Leerink Partners
    1/5/2026$22.00Buy
    Deutsche Bank
    More analyst ratings

    $LMRI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    Lumexa Imaging Announces Participation in Upcoming Investor Conferences

    RALEIGH, N.C., Feb. 17, 2026 /PRNewswire/ -- Lumexa Imaging Holdings, Inc. ("Lumexa Imaging") (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences: Raymond James Institutional Investors Conference, being held in Orlando, Florida, including a presentation at 3:25pm EST on Monday, March 2, 2026.Leerink Partners Global Healthcare Conference, being held in Miami, Florida, including a fireside chat at 8:40am EST on Monday, Marc

    2/17/26 7:30:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging's Dr. Jennifer L. Kemp Elected to RSNA Board, Advancing National Leadership in Quality and Patient-Centered Care

    Chair of Lumexa Imaging's Center for Quality will serve as the Radiological Society of North America's board liaison for government relations RALEIGH, N.C., Jan. 28, 2026 /PRNewswire/ -- Lumexa Imaging (NASDAQ:LMRI), one of the nation's largest providers of outpatient imaging services, is proud to recognize Jennifer L. Kemp, MD, Chair of Lumexa Imaging's Center for Quality, has been elected to the Board of Directors of the Radiological Society of North America (RSNA). "Dr. Kemp's election to the RSNA Board reflects the depth of clinical leadership within our organization and t

    1/28/26 7:00:00 AM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Principal Accounting Officer Walker James Edward Jr. was granted 12,414 shares, increasing direct ownership by 252% to 17,346 units (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    2/27/26 5:40:01 PM ET
    $LMRI
    Medical Specialities
    Health Care

    Chief Financial Officer Martin James Anthony was granted 54,054 shares (SEC Form 4)

    4 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    1/15/26 12:51:17 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Martin James Anthony

    3 - Lumexa Imaging Holdings, Inc. (0002071288) (Issuer)

    1/15/26 12:49:28 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    SEC Filings

    View All

    $LMRI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    3/2/26 6:14:27 AM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form SCHEDULE 13G filed by Lumexa Imaging Holdings Inc.

    SCHEDULE 13G - Lumexa Imaging Holdings, Inc. (0002071288) (Subject)

    2/13/26 2:36:25 PM ET
    $LMRI
    Medical Specialities
    Health Care

    SEC Form 8-K filed by Lumexa Imaging Holdings Inc.

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    1/15/26 6:48:58 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings upgraded by Raymond James with a new price target

    Raymond James upgraded Lumexa Imaging Holdings from Outperform to Strong Buy and set a new price target of $23.00

    2/9/26 8:16:45 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Analyst initiated coverage on Lumexa Imaging Holdings with a new price target

    Analyst initiated coverage of Lumexa Imaging Holdings with a rating of Overweight and set a new price target of $23.00

    1/5/26 9:16:52 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Jefferies initiated coverage on Lumexa Imaging Holdings with a new price target

    Jefferies initiated coverage of Lumexa Imaging Holdings with a rating of Buy and set a new price target of $23.00

    1/5/26 8:58:21 AM ET
    $LMRI
    Medical Specialities
    Health Care

    $LMRI
    Leadership Updates

    Live Leadership Updates

    View All

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials